Please type your full address or zip code below.

Cancel Submit
Dale F. Kraemer, Ph.D.

Dale F. Kraemer, Ph.D.

Research Associate Professor
Department of Neurology

Professional Education
  • Professional Education: University of Iowa, Iowa City, IA, USA
  • Professional Education: Purdue University, West Lafayette, IN, USA
  • Professional Education: Purdue University, West Lafayette, IN, USA

Search for publications by Dale F. Kraemer, Ph.D.

Please note: The resulting entries may not reflect a complete or accurate listing for Dale F. Kraemer, Ph.D. Many journals are not indexed by PubMed, and there may be articles by other authors of the same name listed by this search.

Academic Office
6th Floor, Tower II
580 West 8th Street, T17
Jacksonville, FL 32209
(904) 244-9922
Administrative Assistant
Erica Guerrido
(904) 244-9620
  • Colorectal Cancer Screening in a Primary Care Center

    Purpose: The purpose of this study is to see how many individuals, ages 50 years or older, received colorectal cancer screening. The second purpose is to encourage patients not previosly screened for colorectal cancer to obtain screening. While receiving reminder letters and obtaining colorectal cancer is a part of routine medical care, understanding the reasons why patients do not want screening and knowing how many patients fail to receive screening is considered research.
  • Effects of Treatment with Immunomodulators and Biologic Agents on Sleep Quality in Inflammatory Bowel Disease Patients

    Purpose: This study will assess how inflammatory bowel disease affects sleep. We would specifically like to know if IBD-related treatment agents (e.g. immunomodulators and biological agents) impact sleep pattern. Additionally other factors will also be study to assess whether there are other confounding causes which can contribute to disturbed sleep (e.g. female gender, disease location, IBD related surgery). With the information gathered we hope to improve current IBD maintenance protocol to provide quality care for our IBD patients.
  • IRMA 2014: Impact of Ranolazine on Inflammatory, Thrombogenic, Lipogenic, Biomarkers in Women with Angina and Metabolic Syndrome

    Purpose: More than 5 million women are living with chronic stable angina (CSA) today compared to 4 million men. Similarly more women than men are affected with the metabolic syndrome (MBS). MBS is a group of cardiovascular risk factors such as pre-hypertension, poorly controlled cholesterol, and poorly controlled glucose levels. The metabolic syndrome leads to an increased risk of cardiovascular disease and type 2 diabetes in apparently healthy individuals. It is associated with advanced vascular damage and poorer health outcomes in those with cardiovascular disease (CVD). The reason for this gender difference in angina and MBS is unclear. Ranolazine is a drug the Food and Drug Administration (FDA) has approved for the treatment of angina. It has also had favorable effects on glycemic control. The purpose of this study is to investigate the potential additional benefits of ranolazine in women with CVD and MBS and to evaluate the ability of ranolazine to decrease angina. Secondary, this study will look at certain biomarkers in a group of ethnically diverse women with CSA and with MBS.
  • Pilot Study of a Novel Splint Treatment for Thumb CMC Joint Arthritis: A Comparison of Oval-8 Splinting vs. Standardized Treatment with Tee Pee or Forearm Based Thumb Spica Splinting

    Purpose: This study aims to compare the effects of oval-8 splinting of the hyperextended thumb IP joint vs tee-pee splinting vs. forearm thumb spica splinting on pain and function of patients with thumb CMC joint arthritis.
  • Pilot Study of the Use of Telemedicine in the Care of ALS Patients

    Purpose: The purpose of this study is to evaluate a method of telehealth care in which a trained nurse performs comprehensive evaluations in patients’ homes. If you agree to participate in this study you will receive telehealth care in your home. The visits will be videotaped and viewed by the ALS Care Team who will make recommendations. The patients, caregivers and ALS Care Team will rate their satisfaction with the outcome of the telehealth care in order to determine if this is a good way to evaluate patients.
  • Showing 1 to 5 of 5
0:00 / 0:00